Talc, ovarian cancer
Johnson & Johnson proposes to pay $6.5B to settle talc ovarian cancer lawsuits in US
Through a bankruptcy filing of its subsidiary company, J&J will be able to resolve about 99.75% of the pending talc lawsuits against the company and its affiliates in the U.S.
Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer, pending approval of the claimants.
Ovarian cancer lawsuits: J&J subsidiary offers $6.48 billion to settle
A subsidiary of Johnson & Johnson has proposed a settlement of $6.48 billion over 25 years for lawsuits alleging that its baby powder containing talc caused ovarian cancer
Johnson & Johnson offers to pay $6.5 billion to settle talc ovarian cancer lawsuits
Plaintiffs have three months to vote on whether to approve a proposed legal settlement that would resolve nearly all talc lawsuits.
J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits
A subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer.
J&J proposing to pay $6.5B to resolve almost all talc ovarian cancer suits
A subsidiary of Johnson & Johnson (J&J) is proposing to pay more than $6.5 billion to resolve nearly all the talc ovarian cancer lawsuits brought against the company. J&J said that the
Johnson & Johnson Proposes Nearly $6.5B Package to Settle Talc Ovarian Cancer Suits
Johnson & Johnson said Wednesday that claimants would have three months to vote for or against the proposed settlement, which would resolve nearly all the pending suits that accuse J&J's talc powder of causing cancer.
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
Johnson & Johnson said it will pay $6.5 billion to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer. The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company,
Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits
THURSDAY, May 2, 2024 (HealthDay News) -- Johnson & Johnson announced Wednesday that it would pay out more than $6.5 billion over the next 25 years to settle existing lawsuits claiming that its talc-containing products caused ovarian cancer. The settlement still awaits approval from claimants.
J&J Advances $6.475 Billion Settlement of Talc Cancer Lawsuits
Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause ovarian cancer,
Johnson & Johnson moves forward with $6.475 billion settlement of talc cancer lawsuits
Johnson & Johnson is moving forward with a proposed settlement of tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer.
today.rowan3d
Research team finds potential method for earlier ovarian cancer detection
Gregory Caputo, Ph.D., a professor of chemistry and biochemistry in the College of Science & Mathematics, is part of a ...
News Medical on MSN7d
New blood test shows promise in early detection of ovarian cancer
A study reveals that glycoproteins in blood could be key biomarkers for early detection and staging of epithelial ovarian ...
The American Journal of Managed Care4d
BRCA-Like Classification May Be a Useful Biomarker for Olaparib Response in Ovarian Cancer
Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ...
Ovarian cancer and fertility: Know the risks
Ovarian cancer impacts fertility significantly. Risks, fertility preservation options, alternative conception methods, and ...
Yahoo Finance3d
The World Market for Ovarian Cancer Drugs to 2030: Breakthroughs in Combination Drug Therapy Transforming Standards of Care
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Market Size and Forecast 2020-2030 by Type, Drug Class, ...
FiercePharma4d
J&J nears sweeping resolution to long-standing talc litigation
Thanks to a new reorganization plan, Johnson & Johnson is on the cusp of settling more than 50,000 lawsuits linking its ...
Lynn News on MSN4d
Liz Truss visits Parliament with Downham Market woman Diane Boothby to raise awareness of ovarian cancer
Liz Truss has become a champion for the Target Ovarian Cancer charity in a bid to reduce the death toll brought on by the ...